Liver function in patients with hematological malignancies and HCV infection undergoing chemotherapy.

被引：0
|
作者：
Zuckerman, T
Zuckerman, E
Douer, D
Fong, TL
Nathwani, BN
Velankar, M
Gutekunst, K
Qian, GD
Levine, AM
机构：
[1] UNIV SO CALIF,DEPT PREVENT MED,LOS ANGELES,CA 90089
[2] UNIV SO CALIF,DIV HEMATOL,LOS ANGELES,CA
[3] UNIV SO CALIF,DIV HEMATOPATHOL,LIVER UNIT,LOS ANGELES,CA
[4] ROCHE MOL SYST,SOMERVILLE,NJ
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：878 / 878
页数：1
相关论文
共 50 条
  • [31] BLOOD PRODUCT SUPPORT IN PATIENTS UNDERGOING CHEMOTHERAPY AND AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES
    SMITH, OP
    PRENTICE, HG
    HAZLEHURST, G
    BROZOVIC, B
    HOFFBRAND, AV
    MEHTA, AB
    CLINICAL AND LABORATORY HAEMATOLOGY, 1991, 13 (02): : 107 - 114
  • [32] In children with hematological malignancies severe liver disease is caused by HBV rather than HCV
    El-Sayed, MH
    Karim, AM
    Mahmoud, MM
    Maina, AM
    Oliveri, F
    Brunetto, MR
    JOURNAL OF HEPATOLOGY, 2001, 34 : 169 - 169
  • [33] Ledipasvir-sofosbuvir in Adolescents With Chronic Hepatitis C and Hematological Malignancies Undergoing Chemotherapy
    El-Sayed, Manal Hamdy
    Ebeid, Fatma S. Elsayed
    Zekri, Abdel-Rahman
    Massetto, Benedetta
    Kersey, Kathryn
    Zhang, Fangqiu
    Gaggar, Anuj
    Elsayed, Walaa
    El-Haddad, Alaa
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 74 (05): : 626 - 630
  • [34] Ledipasvir/Sofosbuvir for 12 weeks is safe and effective in adolescents with chronic hepatitis C virus infection and hematological malignancies undergoing chemotherapy
    El-Sayed, M. H.
    Ebeid, F. S. E. S.
    Zekri, A. R.
    Massetto, B.
    Kersey, K.
    Osinusi, A.
    Zhang, F.
    Brainard, D.
    Elsayed, W.
    El-Haddad, A.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S515 - S515
  • [35] Likelihood of a Subsequent Chemotherapy Induced Nausea and Vomiting Event In Patients with Hematologic Malignancies Receiving Chemotherapy.
    Feinberg, Bruce
    Schwartzberg, Lee S.
    Gilmore, James
    Haislip, Sally
    Jackson, James
    Jain, Gagan
    Balu, Sanjeev
    Buchner, Deborah
    BLOOD, 2010, 116 (21) : 1563 - 1563
  • [36] Steatotic liver disease in the context of hematological malignancies and anti-neoplastic chemotherapy
    Pontikoglou, Charalampos G.
    Filippatos, Theodosios D.
    Matheakakis, Angelos
    Papadaki, Helen A.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 160
  • [37] Oral Mucositis in Patients with Hematologic Malignancies Undergoing Chemotherapy
    Viviane Almeida Sarmento
    Davi Silva Carvalho Curi
    Thaiane Dantas Dias dos Santos
    Renata Portela de Rezende
    Liliane Lins-Kusterer
    Patrícia Leite-Ribeiro
    SN Comprehensive Clinical Medicine, 2021, 3 (10) : 2149 - 2153
  • [38] PROLONGED FOLLOW-UP OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES INFECTED BY HBV AND HCV
    Kulikov, S.
    Garmaeva, T. S.
    Mihailova, E.
    Sudarikov, B.
    Filatov, P.
    Savchenko, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 187 - 188
  • [39] Management of patients with hematological malignancies undergoing coronary artery bypass grafting
    Borde, Deepak
    Gandhe, Uday
    Hargave, Neha
    Pandey, Kaushal
    ANNALS OF CARDIAC ANAESTHESIA, 2013, 16 (01) : 47 - 50
  • [40] Oral manifestations associated with neutropenia in Syrian patients diagnosed with hematological malignancies and undergoing chemotherapy: A cross-sectional study
    Al Beesh, Fatima AlZahraa
    Martini, Nafiza
    Suleiman, Siham
    Aljoujou, Abeer
    MEDICINE, 2024, 103 (02) : E36780
12345